Simvastatin: Difference between revisions
imported>David E. Volk (stub, structure, brand names, bad foods) |
mNo edit summary |
||
| (11 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
{{subpages}} | {{subpages}} | ||
{{Image|Simvastatin structure.jpg|right|250px|Simvastatin, a class I statin.}} | |||
'''Simvastatin'' is a methylated derivative of [[lovastatin]] used treat [[hypercholesterolemia]], to prevent heart attacks and strokes, and to diminish [[athlerosclorosis]]. | '''Simvastatin''' is a [[hydroxymethylglutaryl-coenzyme A reductase inhibitor]] (statin). It is a methylated derivative of [[lovastatin]] used treat [[hypercholesterolemia]], to prevent [[myocardial infarction|heart attacks]] and strokes, and to diminish [[athlerosclorosis]]. It is structurally and functionally similar to the other class I [[statin]]s [[mevastatin]], [[lovastatin]] and [[pravastatin]]. Its IUPAC chemical name is [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl 1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate and its chemical formula is C<sub>25</sub>H<sub>38</sub>O<sub>5</sub>. | ||
==Function== | |||
Simvastatin is effective in reducing total and LDL-cholesterol as well as plasma triglycerides and apolipoprotein B. It inhibits the function of hydroxymethylglutaryl COA reductases, key enzymes in the production of [[cholesterol]]. It also increases LDL catabolism and may interfere with [[steroid]] production. | |||
== | == Brand names == | ||
<div style="-moz-column-count:3; column-count:3;"> | |||
*Cholestat | *Cholestat | ||
*Coledis | *Coledis | ||
| Line 33: | Line 33: | ||
*Zocor | *Zocor | ||
*Zocord | *Zocord | ||
</div> | |||
==Pharmacology== ===Administration=== Both the drug and its <math>\beta</math>-hydroxyacid metabolite are highly bound (approximately 95%) to human plasma proteins. | |||
===Distribution=== ===Metabolism=== ===Excretion=== | |||
==Toxicity== | |||
[[Drug toxicity]] include | |||
==Drug interactions== | |||
Its [[drug interaction]]s include alcohol and grapefruit juice which should be avoided when taking this medication. | |||
==External links== | |||
{{CZMed}}[[Category:Suggestion Bot Tag]] | |||
Latest revision as of 16:00, 18 October 2024
Simvastatin is a hydroxymethylglutaryl-coenzyme A reductase inhibitor (statin). It is a methylated derivative of lovastatin used treat hypercholesterolemia, to prevent heart attacks and strokes, and to diminish athlerosclorosis. It is structurally and functionally similar to the other class I statins mevastatin, lovastatin and pravastatin. Its IUPAC chemical name is [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl 1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate and its chemical formula is C25H38O5.
Function
Simvastatin is effective in reducing total and LDL-cholesterol as well as plasma triglycerides and apolipoprotein B. It inhibits the function of hydroxymethylglutaryl COA reductases, key enzymes in the production of cholesterol. It also increases LDL catabolism and may interfere with steroid production.
Brand names
- Cholestat
- Coledis
- Colemin
- Corolin
- Denan
- Labistatin
- Lipex
- Lodales
- Medipo
- Nivelipol
- Pantok
- Rendapid
- Simovil
- Simvastatin
- Simvastatina
- Simvastatine
- Simvastatinum
- Sinvacor
- Sivastin
- Synvinolin
- Vasotenal
- Vytorin
- Zocor
- Zocord
==Pharmacology== ===Administration=== Both the drug and its -hydroxyacid metabolite are highly bound (approximately 95%) to human plasma proteins.
Distribution=== ===Metabolism=== ===Excretion
Toxicity
Drug toxicity include
Drug interactions
Its drug interactions include alcohol and grapefruit juice which should be avoided when taking this medication.
External links
The most up-to-date information about Simvastatin and other drugs can be found at the following sites.
- Simvastatin - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).
- Simvastatin - Drug information for consumers from MedlinePlus (U.S. National Library of Medicine).
- Simvastatin - Detailed information from DrugBank.